期刊文献+

蛇毒半胱氨酸蛋白酶抑制剂重组蛋白对小鼠黑色素瘤血管生成拟态的影响及其机制 被引量:6

Effect of recombinant snake venom cystatin on mouse melanoma vasculogenic mimicry and its underlying mechanisms
下载PDF
导出
摘要 目的探讨蛇毒半胱氨酸蛋白酶抑制剂(snake venom cystatin,sv-cystatin)重组蛋白对小鼠黑色素瘤血管生成拟态(vasculogenic mimicry,VM)形成的影响及相关机制。方法建立Matrigel胶肿瘤细胞类血管生成模型,分析sv-cystatin重组蛋白(10、25、50、100、200mg/L)对B16F10细胞VM形成及基质金属蛋白酶-2、9[matrix metalloproteinase-2(MMP-2)、MMP-9]蛋白表达的影响;建立C57BL/6小鼠黑色素瘤实验性肺转移模型,经25、50mg/kg重组蛋白治疗后,应用CD34和过碘酸雪夫(periodic acid-schiff stain,PAS)双重染色法检测肺转移瘤VM形成,免疫组织化学法检测转移瘤MMP-2、MMP-9表达。结果与对照组相比,sv-cystatin重组蛋白作用后B16F10细胞体外VM形成及MMP-2、MMP-9蛋白表达明显减少,并呈剂量依赖性(P<0.05);两治疗组小鼠肺转移瘤VM形成及MMP-2、MMP-9表达明显下降(P<0.05)。结论 sv-cystatin重组蛋白能够抑制VM形成;下调MMP-2、MMP-9表达是其中的机制之一。 Objective To investigate the effect of recombinant snake venom cystatin (sv-cystatin) on vasculogenic mimicry (VM) formation of mouse melanoma in vitro and in vivo and the mechanisms underlying this effect. Methods The effect of recombinant sv-cystatin (10, 25, 50, 100 and 200 mg/L) on VM of mouse melanoma cell B16F10 in vitro was observed by tube-like structure formation. Experimental lung metastasis assay was used to analyze the effect of sv-cystatin (three intravenous injections of 25 or 50 mg/kg) on VM in surface metastatic lesions by CD34 and periodic acid-Schiff (PAS) double staining. Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) expressions in B16F10 cells were assessed by immunocytochemistry in vitro and immunohistochemistry in vivo, respectively. Results The number of VM and the expressions of MMP-2 and MMP-9 were decreased significantly in dose-dependent manner after treatment with an increased dose of recombinant sv-cystatin compared to those in control group (P (0. 05). In vivo, recombinant sv-cystatin administration significantly suppressed lung tumor colonies, VM formation as well as MMP-2 and MMP-9 expressions in C57BL/6 mice (P〈0.05). Conclusion Recombinant sv-cystatin can inhibit VM formation of B16F10 cells via down-regulating the expressions of MMP-2 and MMP-9.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第2期169-174,共6页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.30371747) 福建省科技重大资助项目(No.2002Y003) 福建省自然科学基金指导性科技计划项目(No.2012D117)~~
关键词 蛇毒 半胱氨酸蛋白酶抑制剂 血管生成拟态 黑色素瘤 基质金属蛋白酶-2 基质金属蛋白酶-9 snake venom cystatin vasculogenic mimicry (VM) melanoma matrix metalloproteinase-2(MMP-2) matrix metalloproteinase-9 (MMP-9)
  • 相关文献

参考文献13

  • 1MANIOTIS AJ, FOLBERG R, HESS A, et al. Vascular chan- nel formation by human melanoma cells in vivo and in vitro : vasculogenicmimicry~[J]. Am J Pathol, 1999, 155(3):739- 752. 被引量:1
  • 2张熙,郭世文,尉春艳.星形细胞瘤中血管生成拟态的鉴定及其临床意义[J].西安交通大学学报(医学版),2011,32(2):205-207. 被引量:2
  • 3PLATE KH, SCHOLZ A, DUMONT DJ. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited[J]. Acta Neuropathol, 2012, 124(6) ~763-775. 被引量:1
  • 4XIE Q, TANG N, WAN R, et al. Recombinant snake venom eystatin inhibits the growth, invasion and metastasis of B]6F10 cells and MHCC97H cells in vitro and in vivo [J]. Toxicon, 2011, 57(5) ..704-711,. 被引量:1
  • 5XIE Q, TANG N, WAN R, et al, Recombinant snake venom cystatin inhibits tumor angiogenesis in vitro and in vivo associ- ated with downregulation of VEGF-A165, Fit-1 and bFGF[J]. Anticancer Agents Med Chem, 2013, 13(4)..663-671. 被引量:1
  • 6SEFTOR RE, HESS AR, SEFTOR EA, et al. Tumor cell vas~ culogenic mimicry~ from controversy to therapeutic promise [J]. Am J Pathol, 2012, 181(4) :1115-1125. 被引量:1
  • 7LIU WB, XU GL, JIA WD, et al. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry inhepa- tocellular carcinoma[J]. Med Oncol, 2011, 28 (Suppl 1) :SZ28- 238. 被引量:1
  • 8LI M, GU Y, ZHANG Z, et al. Vasculogenic mimicry., a new prognostic sign of gastric adenocarcinoma[J]. Pathol Oncol Res, 2010, 16(2)..259-266. 被引量:1
  • 9CHEN LX, HE YJ, ZHAO SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down- regulation of the EphA2/PI3K/MMP pathway in a murine cho- roidal melanoma model[J]. Cancer Biol Ther, 2011, 11 ( 2 ) 229-235. 被引量:1
  • 10BISWAS MH, DU C, ZHANG C, et al. Protein kinase D1 in- hibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer [J]. Cancer Res, 2010, 70(5) ..2095-2104. 被引量:1

二级参考文献7

  • 1魏子龙,朱玉德,黄强.肿瘤拟态血管的发现与研究进展[J].肿瘤,2006,26(10):960-963. 被引量:4
  • 2赵静,黄江生,杨爱军,王晨昱,刘伟,李敏.肝细胞癌中血管生成拟态的三维细胞培养及组织学研究[J].癌症,2007,26(2):123-126. 被引量:24
  • 3MANIOTIS AJ,FOLBERG R,HESS A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155(3):739-752. 被引量:1
  • 4VAN DER SCHAFT DW,HILLEN F,PAUWELS P,et al.Tumor cell plasticity in ewing sarcoma,an alternative circulatory system stimulated by hypoxia[J].Cancer Res,2005,65(24):11520-11528. 被引量:1
  • 5SU M,FENG YJ,YAO LQ,et al.Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo[J].Int J Gynecol Cancer,2008,18(3):476-486. 被引量:1
  • 6SUN B,QIE S,ZHANG S,et al.Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors[J].Human Pathol,2008,39(3):444-451. 被引量:1
  • 7PAULIS YW,SOETEKOUW PM,VERHEUL HM,et al.Signalling pathways in vasculogenic mimicry[J].Biochim Biophys Acta,2010,1806(1):18-28. 被引量:1

共引文献1

同被引文献189

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部